大行評級丨傑富瑞:百勝中國展示成本效益能力 維持“買入”評級
百勝中國(9987.HK)中期純利4.99億美元,同比升2.7%;派每股中期息16仙,上年同期派13仙。傑富瑞發表報吿指,百勝中國第二季純利2.12億美元,同比上升8%,維持“買入”評級,目標價351.6港元。富瑞表示,百勝中國第二季銷售分別較市場及該行低4%及3%,肯德基(KFC)的同店銷售大致符合預期;必勝客的同店銷售則低過預期,不過其毛利率則好過預期。整體而言,在艱難的宏觀環境下,公司展示了成本效益的能力。此外,公司維持今年淨開1500至1700新店的目標,資本開支介乎7億至8.5億美元。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.